Inhaler usability of a pressurized metered dose inhaler and a soft mist inhaler in patients with COPD: A simulated-use study

Chron Respir Dis. 2019 Jan-Dec:16:1479972318787914. doi: 10.1177/1479972318787914. Epub 2018 Jul 17.

Abstract

The objective of this study was to evaluate task performance and handling errors with soft mist inhalers (SMIs) or pressurized metered-dose inhalers (pMDIs) among patients with chronic obstructive pulmonary disease (COPD) experienced with, but not recently trained in, using these devices. This exploratory, noninterventional, simulated-use study (D5970R00004) assessed handling/usability of SMIs and pMDIs in inhaler-experienced patients with COPD (40-78 years; diagnosis ≥6 months). Patients received a device and instruction-for-use leaflet but no training and were recorded while performing tasks required for checking the device, priming, and dosing. Errors that could substantially affect the lung-delivered dose were considered critical. Sixteen of 61 patients (52% male) had used SMIs and 55 had used pMDIs. Thirty-one patients received an SMI and 30 a pMDI. Overall, 79% made ≥5 performance errors (SMI 94%; pMDI 63%) and 49% made ≥5 critical errors (SMI 68%; pMDI 30%). All patients made ≥1 error; three (all pMDI) made no critical errors. Regardless of the device used and previous inhaler experience, patient-centered training, education, and continuous retraining on correct inhaler use should be key aspects of routine patient care in COPD.

Keywords: Chronic obstructive pulmonary disease; bronchodilator agents; inhalation; metered dose inhalers; patient compliance; soft mist inhalers.

Publication types

  • Multicenter Study

MeSH terms

  • Administration, Inhalation
  • Adult
  • Aged
  • Aged, 80 and over
  • Bronchodilator Agents / administration & dosage*
  • Dose-Response Relationship, Drug
  • Equipment Design
  • Female
  • Follow-Up Studies
  • Humans
  • Male
  • Metered Dose Inhalers / statistics & numerical data*
  • Middle Aged
  • Patient Compliance*
  • Pulmonary Disease, Chronic Obstructive / drug therapy*
  • Retrospective Studies

Substances

  • Bronchodilator Agents